Biomed Israel 2022: The 20th National Life Science & Technology Week • May 10-12, 2022 | David InterContinental • Tel Aviv, Israel

Satellite Events

May 10th, 2022

NRX Pharma Private Lunch Reception


Robert Besthof, M.I.M., Interim CEO, Randy Guggenheimer, Chief Business Officer, Jonathan Javitt, M.D., M.P.H., Founder & Chief Scientific Officer, NRx Pharmaceuticals, Inc.

Teva Pharmaceutical Industries Afternoon Workshop

Biomed Israel 2022 Conference Gala Reception

May 11th, 2022

Latham & Watkins LLP Private Breakfast Workshop

Topic: US & EU Life Sciences Regulatory Developments Workshop  – US FDA, US Healthcare Reimbursement and EU Regulatory


Stuart Kurlander, Partner, Ben Haas, Partner Eveline Van Keymeulen, Partner, Josh Kiernan, Partner, Michael Rosenberg, Counsel, Latham & Watkins

Hogan Lovells Private Lunch Reception

Topic: 2022 Regulatory Outlook: Medical technology and digital health trends emerging from the pandemic


Michael S. Heyl, Michael (Moshe) Kasser, Stuart M. Langbein, Kelliann H. Payne, Fabien Roy, Jodi Scott

Medison and Biogen Private Workshop:
leading a summit on Biopharma / Digital Health collaboration

Topic: Crossing the Chasm: Achieving a Successful Partnership with Biopharma in Digital Health


Steff Bristol, Head of External Innovation & Alliances for AI/ML, and Imaging, Biogen Digital Health, Dr. Nadav Shimoni, Head of Digital health sector, Arkin Holdings, Dr. Matan Soll – Digital analyst, Medison Ventures, Orel Hashmatia – Co-founder & CEO, Causalis.ai, Talor Sax – CEO and partner, eHealth Ventures


Greenberg Traurig Private Seminar on current trends in the public and private Capital Markets and M&A arena as well as ways to navigate the current SPAC environment

Topic: Raising Capital, M&A, SPACs and other Exits in the United States


Alan Annex, Co-Chair of Greenberg Traurig’s Global Corporate Practice, Nissim Darvish, Managing Partner of MeOhr Ventures, Bob Grossman, Chair of Greenberg Traurig’s Israel Practice and Corporate Shareholder, Andy Kaye, President and CIO of OurCrowd, Gil Bar-Nahum, Managing Director and EMEA Head of Biotechnology in the Global Healthcare Investment Banking Group of Jefferies


May 12th, 2022

BTG Ferring Private Breakfast Reception